To P2P, or not to P2P? That is the question…

21.4.2020

In the wake of the completing of the National Veterinary Care sale to VetPartners, we thought it would be interesting to present a summary of P2P transactions in Australia over the last 2 years, and see what the data tells us about P2P. P2P simply means the takeover of a listed (public) company so that it then becomes a private company, either independently (typically with the backing of a financial sponsor) or as part of a larger company (ie. a strategic buyer).

Over the last 2 years in Australia, 56 listed companies have been the subject of public to private (P2P) takeover attempts.

Of the 56 P2Ps in the last 2 years:

  • 19 have been from international strategic investors, eg. DuluxGroup (Nippon Paint – Japan), GBST Holdings (FNZ Group – UK), Ruralco (Nutrien – Canada), Bellamys Australia (China Mengniu Dairy – China), ERM Power (Shell – Netherlands);
  • 15 have been from International private equity investors, eg. MYOB (KKR), Scottish Pacific (Affinity Equity Partners), Greencross Vets (TPG);
  • 11 have been from Australian strategic investors, eg. Fairfax Media (Nine Entertainment), Xenith IP (IPH), Chalmers (Qube Logistics); and
  • 11 have been from Australian private equity investors, eg. Navitas (BGH consortium), and Zenitas Healthcare (Adamantem).

Given the number of transactions that have occurred, we decided to run the numbers to see what premiums are being paid, and the factors that influence this premium.

Focusing on the takeover price compared to the 3-month VWAP (Volume Weighted Average Price):

  • The average premium across all transactions was 41%;
  • The average for strategic investors was 53%, compared to 33% for PE deals;
  • The average for successful deals was 43%, compared to 23% for unsuccessful deals;
  • Where a strategic investor was involved, the average premium paid by international investors was 57%, compared to 48% for local buyers;
  • The average where there were multiple bidders was 43%, compared to 40% where there was only one bidder.

The summarised data is presented in the following table.

These conclusions confirm what you would expect, and highlight that there can be a substantial difference in the price paid depending on the nature of the investor. Listed takeover targets can’t always control their fate, but they can control their preparation. We recommend always having a defence pack ready, and a plan for how to engage the bidders most likely to pay a strategic premium.

30.10.2024

Employee Q&A: Anuk Manchanda

We recently sat down for a chat with Anuk Manchanda, our talented M&A Director here at InterFinancial. With over 12 years of solid experience under his belt, Anuk shares what drives his passion for M&A, how he builds meaningful client relationships, and the key lessons he’s picked up along the way. With a background that […]

Read more
30.10.2024

China M&A market briefing as of October 2024

The Chinese economy is undoubtedly undergoing fundamental shifts due to a combination of factors, including slowed economic growth, ongoing political tensions with the West, a large aging population and changing demographics. Since the beginning of 2024, the capital market in China has witnessed several significant shifts in various industries and sectors.   Sluggish IPO market; […]

Read more
30.10.2024

Becoming Investor Ready is more than a stroke of luck

Imagine if you had access to a crystal ball 2 – 3 years before you raise capital or sell your business. What insights would you seek to make sure you’re getting the best possible valuation? This foresight, if it existed, would be invaluable. It will allow you plenty of time to make strategic improvements, strengthen […]

Read more
30.10.2024

Sector dashboards October 2024

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
29.9.2024

Sector dashboards September 2024

Our monthly sector dashboards are out! Our dashboards look at the valuation multiples across seven key sectors, each made up of a number of subsectors. The data takes into account the sale prices of similar companies based on; products, end markets, services, assets classes or other characteristics. The publications include all companies listed on the […]

Read more
29.9.2024

Investing in Consumer Goods and Retail: is it time to go shopping?

It’s been a challenging few years for Consumer Goods and Retail companies. The pandemic, supply chain disruptions, rising interest rates and cost of living pressures have all had an impact on profits in the sector.   Of course, some companies did quite well during the pandemic. Think online shopping, home delivery meal boxes and camping […]

Read more
17.9.2024

From lab coat to deal sheet: celebrating Michael Kakanis’ journey to Director

We’re thrilled to announce the promotion of Michael Kakanis to Director at InterFinancial and his recent appointment as Co-Chair of Healthcare at Clairfield International.   Michael’s journey is nothing short of inspiring. Working as a lecturer in Physiology and Biochemistry while completing his PhD in Immunology, Michael was all set for a long career in Academia. […]

Read more
03.9.2024

7 key challenges to overcome when investing in Australian renewable energy

Properly understanding the potential financial returns of an investment in the context of operations in the Australian Energy market  Renewable energy generation projects utilising solar, wind and battery technology find revenue sources from offtake agreements, arbitrage of wholesale electricity prices, providing grid stabilization services via mechanisms such as FCAS and by accessing green trading certificates […]

Read more
27.8.2024

Employee Q&A: Nasia Christodoulou

At InterFinancial, our strength lies in the passion and expertise of our talented team. Today, we’re shining the spotlight on Nasia Christodoulou, who joined us as a Research Assistant in January 2023 and has since progressed to Analyst. In this Q&A, Nasia gives us a glimpse into her daily routine, the challenges she overcomes, and […]

Read more